Gastroenterology clinical trials recruiting in Illinois

58 recruiting gastroenterology trials match in Illinois. Showing 20.

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.Recruiting

  Phase 2 · Sanofi · Glenview, Illinois

• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Recruiting

  Phase 3 · 89bio, Inc. · Chicago, Illinois

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Morton, Illinois

• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenRecruiting

  Phase 2 · AbbVie · Hot Springs, Arkansas

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Recruiting

  Phase 2 · Genentech, Inc. · Chicago, Illinois

• Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver DiseaseRecruiting

  Phase 2 · Justin Ryder · Chicago, Illinois

• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Oklahoma City, Oklahoma

• A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative ColitisRecruiting

  Phase 2 · Pfizer · Chicago, Illinois

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Evanston, Illinois

• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisRecruiting

  Phase 3 · Akero Therapeutics, Inc · Chicago, Illinois

• Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesRecruiting

  Phase 2 · Northwestern University · Chicago, Illinois

• A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel SyndromeRecruiting

  N/A · PGP Health · Bolingbrook, Illinois

• An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisRecruiting

  N/A · Pfizer · Chicago, Illinois

• A Study to Test Whether BI 3032950 Helps People With Ulcerative ColitisRecruiting

  Phase 2 · Boehringer Ingelheim · Gurnee, Illinois

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Chicago, Illinois

• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseRecruiting

  Phase 4 · Takeda · Chicago, Illinois

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Des Plaines, Illinois

• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruiting

  Phase 2 · AbbVie · Chicago, Illinois

• Treatment of Moderate to Severe Refractory Crohn's DiseaseRecruiting

  Phase 1 / Phase 2 · Tr1X, Inc. · Chicago, Illinois

• Abbott Cephea Mitral Valve Disease RegistryRecruiting

  N/A · Abbott Medical Devices · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.